Status and phase
Conditions
Treatments
About
A multicenter, randomized, double-blind, phase 3 study to evaluate efficacy and safety of HCP1803 in patients with essential hypertension
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients with essential hypertension whose blood pressure measured in visit1 corresponds to the following conditions
Patients with essential hypertension who meet 140 mmHg ≤ mean sitSBP < 180 mmHg and 60 mmHg ≤ mean sitDBP < 110 mmHg at Visit 2
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
361 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal